Atorvastatin in Moderate Active Crohns Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

October 31, 2007

Conditions

Crohns Disease

Interventions

DRUG

Atorvastatin

Trial Locations (1)

Department of Medicine, Division of Gastroenterology and Hepatology, Malmo

All Listed Sponsors

lead

Skane University Hospital

OTHER

NCT00454545 - Atorvastatin in Moderate Active Crohns Disease | Biotech Hunter | Biotech Hunter